Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme

This publication has 26 references indexed in Scilit:

• Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
• Heparin binding to lipoprotein lipase and low density lipoproteins
  FEBS Letters, 1985
• Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin
  European Journal of Clinical Investigation, 1985
• Comparison of the Antithrombotic and Haemorrhagic Effects of Heparin and a New Low Molecular Weight Heparin in Rats
  Pathophysiology of Haemostasis and Thrombosis, 1985
• Hepatic and extrahepatic uptake of intravenously injected lipoprotein lipase
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
• The effect of the chain length of heparin on its interaction with lipoprotein lipase
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1983
• Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis.
  BMJ, 1982
• A Direct Spectrophotometric Microassay for Sulfated Glycosaminoglycans in Cartilage Cultures
  Connective Tissue Research, 1982
• Rapid removal to the liver of intravenously injected lipoprotein lipase
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979
• Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombin
  FEBS Letters, 1976